frank miller 60 minutes oobleck justin timberlake marine corps ball frank gore injury frank gore injury makana
Sunday, January 1, 2012
Verizon Will Charge You Extra to Pay Your Bill Online [Verizon]
HTC EVO Design 4G and Hero S kernel source released
HTC has released the kernel source for the EVO Design 4G, and its US Cellular cousin, the HTC Hero S. The specific version is 2.6.35 for Gingerbread, which is the current kernel running on the devices. Having kernel source opens up some ridiculously cool mods and hacks, and the development community should have plenty of fun with this. This means that we'll all be having fun shortly after. If you're an interested developer, hit the link below and grab some code.
Source: HTC Developers
 |  |
Source: http://feedproxy.google.com/~r/androidcentral/~3/Gfr1Cee0ixk/story01.htm
katharine mcphee miranda kerr occupy la adriana lima victoria secret angels fox 4 fox 4
Saturday, December 31, 2011
UK military uses modded video games for soldier training
Ministry of Defense adapting battle video games
The British Ministry of Defense is turning to technology in order to train its soldiers. One such example is the virtual trainer called Virtual Battlespace 2, which is a modified version of a popular commercial video game. The need stems from hopeful soldiers who are used to popular and appealing video games for the Xbox 360 and PlayStation 3 gaming consoles.
Also, the Ministry is looking at supplying fighter pilots with iPads that can house training and flight manuals and save them money, as paper manuals can cost thousands of dollars and need to be updated.
The Ministry of Defense representatives say the gaming industry and each game developer have a much bigger budget than they do to develop battlefield simulators. The Ministry may buy game code from the publishers and adapt it for their purposes. Virtual Battlespace 2 was based on tech licensed from the developers of Operation Flashpoint, for example.
The changes include making more realistic weapons that behave as they would in the real world, with realistic range. This is to boost the level of immersion and boost realism at the cost of entertainment. [via The Guardian]
Source: http://feeds.electronista.com/click.phdo?i=835fb8d56eac7259e324c8fdd0a1a5b4
rose bowl twilight zone jello shots bowl games abc store times square lobster recipes
Romney tries to come across as a man of the people (AP)
MASON CITY, Iowa ? Dressed in jeans, shirt sleeves rolled up, Mitt Romney reminisced before a noontime crowd about the long car trips his family took when he was a boy. "My dad made Ramblers, so we had one," the Republican presidential hopeful said.
In fact, Romney's father didn't just make cars. He was chairman and president of American Motors, the company that made Ramblers, and a highly successful businessman before he entered politics. It's a detail the son omitted as he sought to establish a bond with Iowans he hopes will support him in next week's presidential caucuses.
An oversight, perhaps ? he sometimes mentions George Romney's titles ? but Romney's effort to come across as a man of the people has been anything but a smooth transition.
One woman recently told him that she had to endure a five-hour commute to work because her company moved out of state. How could he help keep good jobs in Iowa, she asked.
"Sometimes it's counterintuitive," replied Romney, a former businessman, explaining that businesses often invent new, more efficient ways to compete.
"The term is called productivity. Output per person," he said. "Our productivity equals our income."
In the final stretch of the Iowa caucus campaign, Romney has stepped out from behind the curtain of private fundraising events that for months shielded him from unscripted encounters with voters.
During two bus tours through Iowa and New Hampshire, he has overhauled his campaign style. He has done interview after interview. He's knocked on doors and spent hours taking questions from voters in town hall meetings.
His wife, Ann, introduces him at almost every stop, as she did in Mason City on Thursday when she said, "It was Mitt who brought me through my darkest hour" ? an apparent reference to how her husband stood by her through a diagnosis of multiple sclerosis.
She's sat next to him during TV interviews. In a rare display of public emotion, Romney's voice nearly caught as he talked about her struggle with MS on a Sunday news show.
"We're finding that as we run ads that talk about our personal background, our personal beliefs, that that increased support for my campaign," he told reporters who followed his New Hampshire bus tour the week before Christmas. He was explaining his latest TV ads in Iowa ? one highlighted his background as a man of "steadiness and constancy," the other featured his wife talking directly to the camera about his character.
Yet he can still struggle to connect with people on a personal level.
When one retired firefighter in New Hampshire said he was drawing a reduced Social Security check because he also had a state pension, the former Massachusetts governor was less than sympathetic. "If there's a competition for who will give you the most free stuff, go vote for that guy."
When the man said he wasn't asking for any handouts, Romney said, "You knew what you were getting into. ... I wish you well, but I'm not going to promise you more bucks."
He's not always distant. At an earlier stop in New Hampshire, Romney explained how he lived on a careful budget as a Mormon missionary, using crude toilets and living in modest apartments. He also talked about his time as a lay pastor in Boston's Mormon church, when he says he counseled struggling families.
"When people don't have a job and they don't feel like they're contributing to the betterment of their family and their future, they get pretty depressed," he told the crowd. "Being out of work for a long time is real tough and it's not the fault of the person's that out of work."
When a voter in Bethlehem, N.H., asked him how her elderly friends would get through the winter with the price of heating fuel so high, Romney didn't hesitate.
"You're finding throughout this country that it's harder and harder on middle-income families," he said. "The costs of oil, the costs of food, and health care have all gone up."
But when he's trying to connect one-on-one, he sometimes hits notes that sound jarring.
As he stood at the cash register at a Concord, N.H., toy store, picking up a few gifts for charity, a patron asked him what he gave his family for Christmas. Earlier in the day, he had bought his wife a $285 North Face jacket as a gift, he said.
For his sons?
"We sent them checks," said Romney, a multimillionaire. "Cash is always good."
___
Follow Kasie Hunt on Twitter at http://www.twitter.com/kasie.
peter schiff matt holliday project runway winner project runway winner hunter s thompson hunter s thompson berkman
First Meteor Shower of 2012 Arrives Next Week (SPACE.com)
In 2011, most of the best meteor showers occurred when the moon was close to full. This natural "light pollution" made the fainter meteors impossible to see.
But 2012 starts out with a fine meteor shower, the Quadrantids, with absolutely no moon to interfere with the viewing. The?Quadrantid meteor shower ?will peak on Jan. 4 at about 2 a.m. EST (0700 GMT).
Meteor showers occur when the Earth passes through fields of debris left behind by comets or asteroids in the past. The result is that, instead of the handful of meteors, or "shooting stars," which can be seen any clear night, we get a "shower" of meteors: dozens or even hundreds of meteors over the course of an evening.
The best known meteor shower of the year is the Perseids, which normally occurs in the second week of August. The other two most reliable meteor showers are the Geminids in mid-December and the Quadrantids in early January. [Amazing Perseid meteor photos]
Most meteor showers are named for the constellations in which their "radiants" are located. These are the points in the sky from which the meteors appear to streak. When we look at the radiant of a meteor shower, we are essentially looking up the track upon which the meteors arrive at Earth, just as we would watch a train coming down a railroad track.
But after what constellation is the Quadrantid meteor shower named?
Strangely enough, it is named for a constellation which no longer exists, Quadrans Muralis, the wall quadrant. This was an instrument used by early astronomers to measure positions in the sky. If you've ever seen a picture of the famous Danish astronomer Tycho Brahe, you've probably seen his wall quadrant. This constellation was named in 1795 by French astronomer J?r?me Lalande, who had a wall quadrant of his own which he decided to immortalize in the sky.
Quadrans Muralis consisted of a faint group of stars between the top of Bootes and the handle of the Big Dipper, now completely forgotten except for its survival in the name of this meteor shower. The?sky map of the 2012 Quadrantid meteor shower ??included with this article shows where to look to see the shooting star display.?
The comet which created this meteor shower has not been identified for certain, but may have been a comet observed in 1490 by Chinese, Korean, and Japanese astronomers.
Observing a meteor shower is a naked-eye pursuit. The meteors move too fast to be tracked with telescopes or even binoculars. The best way to observe them is to dress warmly and lie back on a deck chair or chaise longue to get as wide a view of the sky as possible.
It?s not necessary to know where the radiant is located, as the meteors can be seen anywhere in the sky. The only important thing is that the radiant be above the horizon. This is not a problem for most observers in North America or Europe since the Quadrantid radiant is circumpolar: it circles the celestial pole and never sets.
You will see more meteors after midnight because of the motion of the Earth. Be sure to protect your eyes from direct light and give your eyes plenty of time to adapt to the darkness, at least 20 minutes.
You may see nothing for some time, but be patient and the meteors will come. Meteors often come in bunches so, if you see one, watch that area more carefully. If you've never observed meteors before, you may think you?re "seeing things" at first, because they often move very fast, and are gone before you can turn your eyes on them.
The Quadrantid shower is unusual for having a very sharp "peak" around 2 a.m. on Jan. 4. Thus it's important to try to observe on this particular date, as the next night will be too late.
Good luck!
This article was provided to SPACE.com by Starry Night Education, the leader in space science curriculum solutions. Follow Starry Night on Twitter @StarryNightEdu.?
bcs standings 2011 rhodes scholarship rhodes scholarship ufc 139 results lee corso lee corso thanksgiving appetizers
Targeted therapy extends progression-free survival of patients with advanced ovarian cancer
ScienceDaily (Dec. 29, 2011) ? Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic Oncology Group (GOG) showed that a targeted therapy called bevacizumab (Avastin) effectively delayed the progression of advanced ovarian cancer. Patients with newly diagnosed advanced ovarian cancer now typically undergo surgery and chemotherapy, but the new research suggests an additional avenue of treatment.
The results of the trial appear in the December 29 issue of the New England Journal of Medicine.
"This approach can be looked upon as a third major component of treatment for ovarian cancer and related malignancies," says Robert A. Burger, MD, lead investigator on the GOG study and director of the Women's Cancer Center at Fox Chase Cancer Center. "We've had the combination of surgical management and cytotoxic chemotherapy for many years, but we haven't really seen anything else in terms of a fundamental class of treatment. This represents a new way for us to control the disease."
The placebo-controlled study, which was sponsored by the National Cancer Institute, enrolled 1,873 patients with previously untreated advanced disease from 336 sites, primarily in the United States, but also in Canada, South Korea, and Japan. The patients either had stage III ovarian cancer that could not be entirely removed with surgery, or stage IV disease, and were randomly assigned to one of three groups. For patients who received bevacizumab with chemotherapy followed by bevacizumab for up to an additional 10 months, the median time until their cancer progressed was 14.1 months, compared to 10.3 months for patients in the control group, who received chemotherapy with a placebo and then continued with a placebo. The net effect was a 28% reduction in the risk of disease of ovarian cancer progression over time. Patients who received bevacizumab only with chemotherapy, but not afterward, had a median progression-free survival of 11.2 months.
The National Cancer Institute estimates that nearly 22,000 women were diagnosed with ovarian cancer in 2011, and more than 15,000 died of the disease. For patients diagnosed before the cancer has spread, the five-year relative survival rate is about 93 percent (relative survival measures survival of cancer only, independent of other causes of death). But ovarian cancer is insidious -- early symptoms, like bloating, abdominal pain, and trouble eating, are typical of many illnesses and easily dismissed as non-threatening. Women often do not learn they have the disease until it's already spread. In 62 percent of new cases, the patient's cancer has metastasized to distant sites, and the five-year survival rate is just under 27 percent.
Bevacizumab is already FDA-approved for use against some types of colon, lung, kidney and brain cancers; its accelerated approval for metastatic breast cancer was recently revoked by the FDA. The drug acts by binding with vascular endothelial growth factor (VEGF), a protein produced by certain cancers that helps initiate the growth of new blood vessels that feed the tumor. The process of growing new blood vessels is called angiogenesis, and bevacizumab is an angiogenesis inhibitor.
"Bevacizumab blocks the growth factor VEGF, which is important in the process of ovarian cancer progression," says Burger, "and we've seen that this drug is also active in patients with recurrent disease."
Angiogenesis happens at the interface between the host and the disease, which makes it an appealing target for treatment, says Burger, who also led the Phase II GOG study on using bevacizumab in women with recurrent ovarian cancer. He says different ovarian cancers may appear identical under the microscope but differ biologically, which means they'll respond differently to treatment.
In the NEJM paper, Burger and his co-authors point out that another ovarian cancer trial conducted primarily in Europe called ICON7 demonstrated positive results in using becavizumab in combination with chemotherapy and then continued for up to 7 months.
Co-authors on the NEJM paper include Mark F. Brady, Roswell Park Cancer Institute; Michael A. Bookman, Arizona Cancer Center; Gini F. Fleming, University of Chicago; Bradley J. Monk, Creighton University School of Medicine; Helen Huang, Roswell Park; Robert S. Mannel, University of Oklahoma Health Sciences Center, Oklahoma City; Howard D. Homesley, Wake Forest University School of Medicine; Jeffrey Fowler, James Cancer Hospital at the Ohio State University, Hilliard; Benjamin E. Greer, Seattle Cancer Care Alliance; Matthew Boente, Minnesota Oncology and Hematology; Michael J. Birrer, Harvard Medical School and Massachusetts General Hospital; and Sharon X. Liang, North Shore-Long Island Jewish Health System.
Recommend this story on Facebook, Twitter,
and Google +1:
Other bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by Fox Chase Cancer Center.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Journal Reference:
- Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Helen Huang, Robert S. Mannel, Howard D. Homesley, Jeffrey Fowler, Benjamin E. Greer, Matthew Boente, Michael J. Birrer, Sharon X. Liang. Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer. New England Journal of Medicine, 2011; 365 (26): 2473 DOI: 10.1056/NEJMoa1104390
Note: If no author is given, the source is cited instead.
Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.
Source: http://feeds.sciencedaily.com/~r/sciencedaily/~3/6pQ7tkrjR1c/111229091841.htm
willis mcgahee 2013 ford escape stop online piracy act protect ip act spear of destiny rock hill sc kate middleton pregnant
China executes 12 people in single day (AP)
BEIJING ? China has executed 12 people in a single day, including a man who bombed a local tax office.
The official Xinhua News Agency says Liu Zhuiheng was convicted and sentenced to death for detonating explosives outside a tax office in Changsha city in Hunan province in July 2010. Four people were killed and 17 others wounded. Xinhua says the 52-year-old was venting anger over business losses.
Xinhua says China's supreme court approved the death sentence of Liu and 11 others Thursday. All death sentences are sent to the supreme court for review and are usually carried out immediately if approved.
The other 11 people were convicted of crimes including murder and robbery.
China executes more people than any other country ? around 4,000 people a year.
fox 4 adam levine vs fashion show 2011 victoria secret fashion show beverly hills hotel beverly hills hotel tori spelling
Subscribe to:
Posts (Atom)